Evidence map›Paper›PMID 41714844›Full record

ReviewJournal of biochemistry2026

Cell assays in microcompartments driven by droplet microfluidics and hydrogel technologies.

Kazuki Hattori

Abstract readReview
In one paragraph

Review in Journal of biochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Kazuki HattoriResearch Center for Advanced Science and Technology, The University of Tokyo, 4-6-1 Komaba, Meguro-ku, Tokyo 153-8904, Japan.ORCID 0000-0002-5592-4257

Funding

AMED JP22gm6710008JSPS KAKENHI JP25K22885
6 · The paper itself

Abstract

Microcompartments are miniaturized, uniform units designed to isolate and analyse individual cells, cell pairs, spheroids, or organoids, enabling massive parallel assays. This technique overcomes key limitations of traditional plate-based methods, including limited scale, high cost, and labor-intensive processing. This review highlights technologies that create these compartments, primarily leveraging droplet microfluidics and hydrogel techniques for high-throughput cellular analysis. These platforms are compatible with diverse measurement modalities, including imaging-based readouts for real-time monitoring, barcoded sequencing for multiplexed molecular profiling, and flow cytometry-based sorting for enriching functional populations. For example, water-in-oil droplets serve as picoliter-scale reaction vessels for rapid cell isolation based on antibody secretion profiles, while hydrogel platforms support single-cell clonal expansion for screening and the generation of uniform spheroids for drug testing. By enabling the massive parallelization of functional assays, microcompartment platforms are accelerating biomedical research and therapeutic development.

Indexed as

HydrogelsMicrofluidic Analytical TechniquesMicrofluidicsAnimalsHigh-Throughput Screening AssaysHumansHydrogelsdroplet microfluidicshigh-throughput analysishydrogelscreening

Identifiers

PMID41714844
PMCPMC13201269

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.